RSA-RCT: Attune S+ TKA Versus Sigma TKA — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

RSA-RCT: Attune S+ TKA Versus Sigma TKA — Stella

Recruiting

Back to Osteoarthritis Arthritis trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Netherlands

Haaglanden Medical Center, The Hague, South Holland

Key details

Sponsor

Peter den Hollander

Collaborators

Leiden University Medical Center

Enrollment target

~64 participants

Started

November 2019

Primary completion

June 2026

Age range

21 Years – 90 Years

Last updated October 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov